Minutes - FHIR Validation Group 2024-08-29

Agenda

• New Topics
  • Need for a Published Glossary
  • Business Publication on Website eSanté: Document validated by Stakeholders - For Information
    • Next step: Patient Will
  • Publication of core from the HL7 Core - Follow-up - Bart
  • Update PopulationScreening - Veerle
  • Note au Commité de Gestion - Remarks and Followup - JM
  • FHIR Governance - Add QA + New steps regarding Commité de Gestion & Reporting - JM & Hanne
  • Request for Publication for Medication - Follow-up - Jose
  • FHIR-a-Thon - JM & Karlien
    • There is a need for Clarification about the different versions for Vaccination in RSW vs Vitalink.
• Vaccination topics (from Isabelle)
  • Mise à disposition Mapping codes produits et vaccincodes -> Au niveau de la SAM v2 ? Est-ce que cette action est bien prise ne charge ? par qui ? quels sont les délais ?
  • Publication sur le site eHealth standard du Mapping entre CD-VACCINEINDICATION (Kmehr) et vaccincodes (FHIR) -> normalement promis pour la fin du mois de juin 2024 ; ou en est-on ?
• Reference page for Build/Published Profiles - Meeting with JM & Jose
• Hanne Topics
  • Documentation strategy: what is published when, by whom? -
    • Business rules doc  by esanté?
    • IG + guidance  by ehealth
      • Both documents need to be 100% compatible in term of content
    • What about generic technical information like versioning, use of security labels, use of identifiers, acces… ?
  • FHIR versioning strategy
    • Versioning of FHIR resources  Is there a validated approach? If yes, where to find? If no, how to continue discussion and where to publish?
    • Versioning of FHIR  How to make a transition to another FHIR version work in the ecosystem? We need a clear documented approach, backwards compatibility,…
  • Changes provided by the workgroup
    • How to handle change requests that are provided by the workgroups?
  • Alivia: question on organizing HL7 workgroups
  • Business Docs must be available when the Release Candidate is ready for Feedback, and must be attached to the communication email

• Recurring topics
  • Terminology Center Process
  • Data Dictionary Template
  • Datacapabilities Project - Andries
    • Encounter - Trekker: Pablo
  • Allergy - Request for change from Corilus - Ongoing
  • General Rule Core package
  • Unique Identifier
  • Logical Model Lab IG
  • Patient Death Reporting

• Projects Status
  • Give projects overview for all active projects (Tools related)
  • European Joined Actions feedback

• • Caresets
    • Next steps - Anne
  • Others
• FHIR Strategy
  • FHIR Versioning Strategy
• New Projects Proposal
• New Projects to come
  • Cohbra over FHIR - JM - to be started
• Other Topics
  • Allergy & Snomed: https://github.com/hl7-be/allergy/issues/110

• • 'Must support' deprecation (from Hanne) - To be discussed
    • I am currently in a meeting for Xt-HER (patient summary workshop) where I hear that the ‘MUST SUPPORT’ classification in HL7 FHIR will be deprecated due to possibility on different interpretations. I know this is not the case yet, and I also know that we are in a earlier FHIR version where it will be in use. But due to these future changes I was wondering if we should keep a focus on this classification for the coming projects. It’s an open question maybe to discuss during the next validation team.

• • Feedback Business Publication (from Hanne) - To be discussed
    • Le KB78 n'existe plus et a été remplacé par la Loi relative à l'exercice des professions des soins de santé du 10 mai 2015 (WUG 2015). Je sais que nous parlons toujours des « KB78'ers » etc., mais je ne sais pas si nous pouvons y faire référence dans une publication formelle ?
    • En effet, les publications actuelles sont mentionnées. Tant pour l'Allergie que pour la Vaccination, une nouvelle version a été proposée pour validation. Ne devrions-nous pas, depuis cette page, faire référence aux ‘releasecandidates ? En principe, toute personne connaissant FHIR (et capable de lire un IG) devrait pouvoir évaluer la valeur des deux IGs. Les pages GitHub me semblent également intéressantes ?